Civil Society Calls for Greater Engagement in Rollout of HIV Prevention Drug Lenacapavir As Global Tensions Grow
Civil society organisations in Uganda have raised concerns over limited involvement in the planned rollout of a new long-acting antiretroviral drug, lenacapavir for HIV prevention, urging authorities to ensure inclusive planning and community engagement. The concerns emerged during a virtual meeting convened by HEPS-Uganda on March 17, 2026, which brought together 53 HIV prevention advocates.…